| Product NDC: | 50458-309 |
| Proprietary Name: | RISPERDAL CONSTA |
| Non Proprietary Name: | risperidone |
| Active Ingredient(s): | & nbsp; risperidone |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50458-309 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021346 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20031029 |
| Package NDC: | 50458-309-11 |
| Package Description: | 1 KIT in 1 BOX (50458-309-11) * 2 mL in 1 VIAL * 2 mL in 1 SYRINGE |
| NDC Code | 50458-309-11 |
| Proprietary Name | RISPERDAL CONSTA |
| Package Description | 1 KIT in 1 BOX (50458-309-11) * 2 mL in 1 VIAL * 2 mL in 1 SYRINGE |
| Product NDC | 50458-309 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | risperidone |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20031029 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |